Jose D. Subiela

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications

Adjuvant therapy in renal cell carcinoma. Does the end justify the means? A reflection on KEYNOTE-564 and LITESPARK-022 benefits and harms.

Adjuvant therapy in renal cell carcinoma. Does the end justify the means? A reflection on KEYNOTE-564 and LITESPARK-022 benefits and harms.

Journal: The Journal of urology
Published: August 28, 2026

Re: Can Aydogdu, Laura Bukavina, Liang Cheng, et al. Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.05.030.

Re: Can Aydogdu, Laura Bukavina, Liang Cheng, et al. Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.05.030.

Journal: European urology
Published: July 21, 2026

Enhanced Endoscopic Imaging Technologies in Upper Urinary Tract Urothelial Tumors: Implications for Kidney-Sparing Surgery-A Narrative Review.

Enhanced Endoscopic Imaging Technologies in Upper Urinary Tract Urothelial Tumors: Implications for Kidney-Sparing Surgery-A Narrative Review.

Journal: Diagnostics (Basel, Switzerland)
Published: May 13, 2026

DNA damage response pathway alterations in urothelial carcinoma: a road to precision oncology or a dead-end street?

DNA damage response pathway alterations in urothelial carcinoma: a road to precision oncology or a dead-end street?

Journal: The oncologist
Published: May 11, 2026

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Journal: Future oncology (London, England)
Published: April 27, 2026

Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.

Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.

Journal: ESMO open
Published: April 13, 2026

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

Journal: World journal of urology
Published: April 12, 2026

The updated 2021 EAU risk groups for non-muscle-invasive bladder cancer: what have we learned four years after implementation?

The updated 2021 EAU risk groups for non-muscle-invasive bladder cancer: what have we learned four years after implementation?

Journal: Minerva urology and nephrology
Published: March 24, 2026

Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Journal: BJU international
Published: March 20, 2026

Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody-drug conjugates.

Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody-drug conjugates.

Journal: Cancer treatment reviews
Published: March 19, 2026

Combining ctDNA and utDNA as a Dual Biomarker-driven Strategy for Bladder-sparing Therapy in Muscle-invasive Bladder Cancer: Neither Alone Is Sufficient.

Combining ctDNA and utDNA as a Dual Biomarker-driven Strategy for Bladder-sparing Therapy in Muscle-invasive Bladder Cancer: Neither Alone Is Sufficient.

Journal: European urology
Published: March 19, 2026

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Journal: BJU international
Published: March 13, 2026
Showing 1-12 of 115

Last Updated: 09/26/2026